MKI67 and breast carcinoma: In our study we addressed the question whether a systematic further analysis of different counting methods, based on the problematic issues identified in the previous study of the Swiss Working Group of Gyneco- and Breast-Pathologists can improve the unsatisfactory inter- and intra-observer reliability in Ki-67 LI in midrange breast cancer [3].